Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: New Research, Neuronal Excitability

Reduced Dopamine Signaling Impacts Pyramidal Neuron Excitability in Mouse Motor Cortex

Olivia K. Swanson, Rosa Semaan and Arianna Maffei
eNeuro 23 September 2021, 8 (5) ENEURO.0548-19.2021; https://doi.org/10.1523/ENEURO.0548-19.2021
Olivia K. Swanson
1Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, New York 11794
2Graduate Program in Neuroscience, Stony Brook University, Stony Brook, New York 11794
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosa Semaan
1Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, New York 11794
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arianna Maffei
1Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, New York 11794
2Graduate Program in Neuroscience, Stony Brook University, Stony Brook, New York 11794
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Arianna Maffei
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Whole-cell recordings of excitatory neurons in forelimb M1 were localized to L2/3 and L5. A, Schematic showing the anterior–posterior span of recorded slices, restricted to the forelimb area of M1. B, Recorded neurons were visualized with streptavidin labeling of biocytin and confirmed as excitatory by negative immunoreactivity for GAD67. GAD67 and merged images are shown at one z-plane depth; biocytin images are shown as a collapsed stack spanning the entire neuron. Open arrows, GAD67– biocytin-filled neurons; closed arrows, neighboring GAD67+ interneurons (not recorded) at the same depth. Scale bar, 50 μm. C, Histologic staining of cytoarchitecture used to define cortical layers. Hoechst 33342 stain is a nuclear counterstain of all cells in the region, Neurotrace was used as a neuron-specific stain for somata, SMI-32 labels a subset of pyramidal neurons in layer 3 and layer 5. Scale bar, 200 μm. Right-most panel, Two example neurons localized to L2/3 and L5; neurons localized within 8–35% of the total cortical depth were defined as L2/3; neurons within 35–76% of cortical depth were defined as L5.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Acute D1R blockade shifts excitability of M1 neurons. A, Superimposed responses to hyperpolarizing and depolarizing current steps in individual L2/3 and L5 neurons before and after bath application of D1R antagonist SCH23390 (D1ant, 10 μm). Scale bar: Top, 20 mV, 100 ms; bottom: 10 mV, 100 ms. B–F, Summary excitability plots for excitatory neurons in L2/3 (green) and L5 (blue) before and after D1ant application, in baseline (ACSF) or synaptic blocker (BLK: 20 μm picrotoxin, 20 μm DNQX, 50 μm AP5) conditions. Modified Cumming plots show raw data of individual neurons as lines, overlayed with the mean ± SEM. To the right of each group of raw data are the effect size (black circle), corresponding 95% CIs (black vertical bars), and the underlying bootstrap sampling distribution. B, Dynamic input resistance across hyperpolarizing current steps. C, Voltage dependence of Ih-mediated voltage sag elicited by hyperpolarizing current. D, Action potential threshold at rheobase. E, Action potential half-width at rheobase. F, Action potential frequency during suprathreshold current injections (ACSF L2/3 neurons: N = 6, n = 12; ACSF L5 neurons: N = 6, n = 11; BLK L2/3 neurons: N = 5, n = 10; BLK L5 neurons: N = 6, n = 10. Data are shown as the mean ± SEM. *p ≤ 0.05.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Acute D2R blockade shifts excitability of M1 neurons. A, Superimposed responses to hyperpolarizing and depolarizing current steps in individual L2/3 (green) and L5 (blue) neurons before and after bath application of D2R antagonist sulpiride (D2ant, 10 μm) Scale bar: Top, 20 mV, 100 ms; bottom, 10 mV, 100 ms. B–F, Summary excitability plots for excitatory neurons in L2/3 and L5 before and after D2ant application, in baseline (ACSF) or synaptic blocker (BLK: 20 μm picrotoxin, 20 μm DNQX, 50 μm AP5) conditions. Modified Cumming plots show raw data of individual neurons as lines, overlayed with the mean ± SEM. To the right of each group of raw data are the effect size (black circle), corresponding 95% CIs (black vertical bars), and the underlying bootstrap sampling distribution. B, Dynamic input resistance across hyperpolarizing current steps. C, Voltage dependence of Ih-mediated voltage sag elicited by hyperpolarizing current. D, Action potential threshold at rheobase. E, Action potential half-width at rheobase. F, Action potential frequency during suprathreshold current injections. ACSF L2/3 neurons: N = 5, n = 11; ACSF L5 neurons: N = 5, n = 10; Blk L2/3 neurons: N = 4, n = 8; Blk L5 neurons: N = 4, n = 8. Data are shown as mean ± SEM. *p ≤ 0.05.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Combined D1R+D2R blockade in dopamine-primed slices of M1 recapitulates the results of individual antagonist experiments. A, Superimposed responses to hyperpolarizing and depolarizing current steps in individual L2/3 (green) and L5 (blue) neurons before and after bath application of SCH23390 (D1ant) and Sulpiride (D2ant). Scale bar: Top, 20 mV, 100 ms; bottom, 10 mV, 100 ms. B–F, Summary excitability plots for excitatory neurons in L2/3 and L5 before and after D1ant+D2ant application, in dopamine (10 μm) ACSF. Modified Cumming plots show raw data of individual neurons as lines, overlayed with the mean ± SEM. To the right of each group of raw data are the effect size (black circle), corresponding 95% CIs (black vertical bars), and the underlying bootstrap sampling distribution. B, Dynamic input resistance across hyperpolarizing current steps. C, Action potential threshold at rheobase. D, Action potential half-width at rheobase. E, Voltage dependence of Ih-mediated voltage sag elicited by hyperpolarizing current. F, Action potential frequency during suprathreshold current injections. DOPA L2/3 neurons: N = 7, n = 11; DOPA L5 neurons: N = 5, n = 10. Data are shown as the mean ± SEM. *p ≤ 0.05.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Validation of the 6OHDA model of Parkinson’s disease. A, Unilateral injection of 6OHDA or vehicle, centered on the SNc. B, Schematic of the cylinder motor assessment. C, Quantification of weight-bearing wall touches measured as a ratio of forelimb use contralateral versus ipsilateral to the injected hemisphere. D, Immunolabeled TH+ dopaminergic neurons visualized with DAB in the SNc and VTA. E, Summary of stereological counts of TH+ neurons in the SNc and VTA of lesioned or vehicle-injected animals. (vehicle animals, N = 18; 6OHDA animals, N = 17; data are shown as the mean ± SEM. *p < 0.0001. F, Summary stereological counts of TH+ boutons in M1 of a subset of animals. Vehicle animals, N = 2; 6OHDA animals, N = 2. Data are shown as the mean ± SEM. *p ≤ 0.05.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Nigral 6OHDA lesion shifts M1 neuron excitability, partially recapitulating the effects of D1R antagonist. A, Superimposed responses to hyperpolarizing and depolarizing current steps in individual L2/3 (green) and L5 (blue) neurons of vehicle- and 6OHDA-injected animals. All traces shown are in ACSF conditions. Scale bar: Top, 20 mV, 100 ms; bottom, 10 mV, 100 ms. B–F, Summary excitability plots for excitatory neurons in L2/3 and L5 of vehicle and 6OHDA animals, in baseline (ACSF) or synaptic blockers (BLK; 20 μm picrotoxin, 20 μm DNQX, 50 μm AP5) conditions. Modified Cumming plots show raw data of individual neurons as swarm plots, with the mean ± SEM offset to the right. Further right of each group of raw data are the effect size (black circle), corresponding 95% CIs (black vertical bars), and the underlying bootstrap sampling distribution. B, Dynamic input resistance across hyperpolarizing current steps. C, Voltage dependence of Ih-mediated voltage sag elicited by hyperpolarizing current. D, Action potential threshold at rheobase. E, Action potential half-width at rheobase. F, Action potential frequency during suprathreshold current injections. ACSF L2/3 vehicle neurons: N = 11, n = 16; ACSF L2/3 6OHDA neurons: N = 13, n = 21; BLK L2/3 vehicle neurons: N = 3, n = 7; BLK L2/3 6OHDA neurons: N = 4, n = 8; ACSF L5 vehicle neurons: N = 11, n = 29; ACSF L5 6OHDA neurons: N = 11, n = 29; BLK L5 vehicle neurons: N = 5, n = 14; BLK L5 6OHDA neurons: N = 6, n = 12. Data are shown as the mean ± SEM. *p ≤ 0.05.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Chronic M1 dopamine depletion impacts L2/3 intrinsic excitability. A, Unilateral injection of 6OHDA or vehicle into forelimb region of M1. B, Quantification of weight-bearing wall touches in cylinder motor assessment. C, TH+ axons and boutons labeled in L2/3 of M1 ipsilateral and contralateral to the injection site. Magnification, 40×. Scale bar, 50 μm. D, Stereological counts of TH+ boutons in M1 in lesioned (N = 4) or vehicle-injected (N = 5) animals. E, Stereological counts of TH+ neurons in the SNc and VTA of a subset of animals (vehicle, N = 4; 6OHDA, N = 4). F–K, Summary excitability plots for excitatory neurons in L2/3 (green) and L5 (blue) of vehicle or 6OHDA-injected animals, performed in synaptic blockers (BLK: 20 μm picrotoxin, 20 μm DNQX, 50 μm AP5). Modified Cumming plots show raw data of individual neurons as swarm plots, with the mean ± SEM offset to the right. Further right of each group of raw data are the effect size (black circle), corresponding 95% CIs (black vertical bars), and the underlying bootstrap sampling distribution. F, Superimposed responses to hyperpolarizing and depolarizing current steps in individual L2/3 and L5 neurons in vehicle- or 6OHDA-injected animals. Scale bar: Top, 20 mV, 100 ms; bottom, 10 mV, 100 ms. G, Dynamic input resistance across hyperpolarizing current steps. H, Action potential threshold at rheobase. I, Action potential half-width at rheobase. J, Voltage dependence of Ih-mediated voltage sag elicited by hyperpolarizing current. K, Action potential frequency during suprathreshold current injections. Vehicle L2/3 neurons: N = 4, n = 12; vehicle L5 neurons: N = 5, n = 16; 6OHDA L2/3 neurons: N = 4, n = 14; 6OHDA L5 neurons: N = 4, n = 16. Data are shown as the mean ± SEM. *p ≤ 0.05.

Tables

  • Figures
    • View popup
    Table 1

    Summary statistics table for L2/3 neurons across all experiments

    ExperimentParameternMean
    difference
    CI lower
    limit
    CI upper
    limit
    p Value
    Permutation t testStudent’s t test
    ACSF D1antDIR1229.1513.2546.090.0100.007
    AP threshold12–1.86–2.89–0.830.0090.007
    AP half-width120.110.050.210.0110.017
    BLK D1antDIR1262.9948.5795.310.0010.000
    AP threshold10–1.90–3.69–0.580.0490.048
    AP half-width100.070.020.120.0240.024
    ACSF D2antDIR1120.228.0535.170.0160.019
    AP threshold11–1.50–2.24–0.610.0070.006
    AP half-width11–0.01–0.040.030.4760.472
    BLK D2antDIR810.841.7025.400.1520.126
    AP threshold8–0.89–2.621.160.3920.403
    AP half-width8–0.03–0.060.000.1250.113
    DOPA D1+D2antDIR1126.528.5754.420.0320.046
    AP threshold11–1.99–2.69–1.470.0000.000
    AP half-width110.040.010.070.0500.042
    SNc 6OHDA ACSFVehicle = 16
    DIR6OHDA = 21–9.64–46.1528.890.5950.609
    Vehicle = 16
    AP threshold6OHDA = 210.68–1.362.490.5010.504
    Vehicle = 16
    AP half-width6OHDA = 210.07–0.050.200.3050.303
    SNc 6OHDA BLKVehicle = 7
    DIR6OHDA = 84.78–82.5183.740.9070.917
    Vehicle = 7
    AP threshold6OHDA = 71.50–2.335.910.5340.527
    Vehicle = 7
    AP half-width6OHDA = 70.13–0.070.350.3100.302
    M1 6OHDA BLKVehicle = 12
    DIR6OHDA = 142.90–31.2541.270.8770.884
    Vehicle = 12
    6OHDA = 122.35–0.124.530.0630.067
    Vehicle = 12
    AP half-width6OHDA = 12–0.18–0.33–0.010.0530.050
    • Permutation t test p values are listed alongside Student’s t test p values for comparison. Bold p values indicate a p value ≤ 0.05. AP, Action potential; DIR, dynamic input resistance.

    • View popup
    Table 2

    Summary statistics table for L5 neurons across all experiments

    ExperimentParameternMean
    difference
    CI lower
    limit
    CI upper
    limit
    p Value
    Permutation t testStudent’s t test
    ACSF D1antDIR1116.958.4227.310.0020.007
    AP threshold11–1.30–2.10–0.580.0070.009
    AP half-width110.020.000.040.0670.065
    BLK D1antDIR1245.5630.5065.710.0000.000
    AP threshold10–1.66–3.06–0.380.058**0.047
    AP half-width100.030.000.060.0920.099
    ACSF D2antDIR109.914.0922.430.023**0.053
    AP threshold10–2.59–3.76–1.400.0030.003
    AP half-width10–0.04–0.06–0.020.0130.018
    BLK D2antDIR816.949.5536.710.0000.027
    AP threshold8–2.24–4.83–0.950.024**0.055
    AP half-width8–0.06–0.08–0.040.0000.000
    DOPA D1+D2antDIR1011.082.3620.040.0420.047
    AP threshold10–1.21–1.71–0.690.0040.002
    AP half-width100.040.010.060.0170.017
    SNc 6OHDA ACSFVehicle = 29
    DIR6OHDA = 29–2.55–23.0515.480.8080.803
    Vehicle = 29
    AP threshold6OHDA = 280.67–0.812.150.3910.392
    Vehicle = 29
    AP half-width6OHDA = 280.08–0.030.190.1770.173
    SNc 6OHDA BLKVehicle = 14
    DIR6OHDA = 12–26.11–71.51–1.130.1650.168
    Vehicle = 14
    AP threshold6OHDA = 110.05–2.252.560.9700.971
    Vehicle = 14
    AP half-width6OHDA = 11–0.06–0.190.050.3910.396
    M1 6OHDA BLKVehicle = 16
    DIR6OHDA = 16–9.21–37.7016.810.5320.519
    Vehicle = 16
    AP threshold6OHDA = 160.64–1.372.700.5470.542
    Vehicle = 16
    AP half-width6OHDA = 16–0.06–0.200.070.4340.416
    • Permutation t test p values are listed alongside Student’s t test p values for comparison. Bold p values indicate p ≤ 0.05. AP, Action potential; DIR, dynamic input resistance.

    • **Instances where one statistics test was over/under the 0.05 p value threshold when the other was not.

Back to top

In this issue

eneuro: 8 (5)
eNeuro
Vol. 8, Issue 5
September/October 2021
  • Table of Contents
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Reduced Dopamine Signaling Impacts Pyramidal Neuron Excitability in Mouse Motor Cortex
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Reduced Dopamine Signaling Impacts Pyramidal Neuron Excitability in Mouse Motor Cortex
Olivia K. Swanson, Rosa Semaan, Arianna Maffei
eNeuro 23 September 2021, 8 (5) ENEURO.0548-19.2021; DOI: 10.1523/ENEURO.0548-19.2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Reduced Dopamine Signaling Impacts Pyramidal Neuron Excitability in Mouse Motor Cortex
Olivia K. Swanson, Rosa Semaan, Arianna Maffei
eNeuro 23 September 2021, 8 (5) ENEURO.0548-19.2021; DOI: 10.1523/ENEURO.0548-19.2021
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
    • Synthesis
    • Author Response
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • dopamine
  • excitability
  • modulation
  • motor cortex
  • neurodegeneration
  • neuron

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Deletion of endocannabinoid synthesizing enzyme DAGLα in Pcp2-positive cerebellar Purkinje cells decreases depolarization-induced short-term synaptic plasticity, reduces social preference, and heightens anxiety
  • Release of extracellular matrix components after human traumatic brain injury
  • Action intentions reactivate representations of task-relevant cognitive cues
Show more Research Article: New Research

Neuronal Excitability

  • Tolerance in Thalamic Paraventricular Nucleus Neurons Following Chronic Treatment of Animals with Morphine
  • Investigating Mechanically Activated Currents from Trigeminal Neurons of Nonhuman Primates
  • Postnatal Development of Dendritic Morphology and Action Potential Shape in Rat Substantia Nigra Dopaminergic Neurons
Show more Neuronal Excitability

Subjects

  • Neuronal Excitability
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.